| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Giuseppe Giannaccare | Q88668061 |
| Piera Versura | Q89816872 | ||
| Marina Buzzi | Q56581822 | ||
| P2093 | author name string | Marco Pellegrini | |
| Federico Bernabei | |||
| Matilde Roda | |||
| P2860 | cites work | The ocular surface: the challenge to enable and protect vision: the Friedenwald lecture | Q24633615 |
| Progress in corneal wound healing | Q28081311 | ||
| Autologous serum eye drops for dry eye. | Q30235522 | ||
| Application of umbilical cord serum eyedrops after laser epithelial keratomileusis | Q31096052 | ||
| Treatment of ocular surface syndrome after LASIK with autologous platelet-rich plasma | Q33289210 | ||
| Growth factors: importance in wound healing and maintenance of transparency of the cornea | Q33805838 | ||
| The role of "eye platelet rich plasma" (E-PRP) for wound healing in ophthalmology. | Q33955776 | ||
| Autologous serum eye drops for the treatment of dry eye diseases | Q34013889 | ||
| Umbilical cord blood serum therapy for the management of persistent corneal epithelial defects | Q34390547 | ||
| Treatment of dry eye by autologous serum application in Sjögren's syndrome | Q35309629 | ||
| Evaluation of umbilical cord serum therapy for persistent corneal epithelial defects | Q35591536 | ||
| Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease | Q35592019 | ||
| Autologous serum eye drops for ocular surface disorders | Q35592577 | ||
| Targeting growth factor supply in keratopathy treatment: comparison between maternal peripheral blood and cord blood as sources for the preparation of topical eye drops | Q35699085 | ||
| Comparison of corneal epitheliotrophic capacities among human platelet lysates and other blood derivatives | Q36267618 | ||
| Allogeneic serum eye drops for the treatment of dry eye patients with chronic graft-versus-host disease | Q36281748 | ||
| The corneal fibrosis response to epithelial-stromal injury | Q36382242 | ||
| Epitheliotrophic capacity of serum eye drops from healthy donors versus serum from immunosuppressed patients with rheumatoid arthritis | Q46693383 | ||
| TFOS DEWS II Report Executive Summary. | Q46919939 | ||
| Autologous serum eye drops for dry eye after LASIK. | Q46920180 | ||
| Comparison of Autologous Serum Versus Preservative Free Artificial Tear in Patients with Dry Eyes Due to Systemic Isotretinoin Therapy. | Q47336283 | ||
| Treatment of individuals who cannot receive blood products for religious or other reasons. | Q47553677 | ||
| The levels of 12 cytokines and growth factors in tears: hyperthyreosis vs euthyreosis. | Q47563654 | ||
| Long-term use of autologous serum 50% eye drops for the treatment of dry eye disease. | Q47802474 | ||
| Autologous serum eyedrops in the treatment of aniridic keratopathy. | Q48577610 | ||
| The Royal College of Ophthalmologists guidelines on serum eye drops for the treatment of severe ocular surface disease: full report. | Q49925651 | ||
| The Royal College of Ophthalmologists guidelines on serum eye drops for the treatment of severe ocular surface disease: executive summary. | Q49925673 | ||
| The biology of the platelet with special reference to inflammation, wound healing and immunity. | Q49991964 | ||
| Efficacy of 2-Month Treatment With Cord Blood Serum Eye Drops in Ocular Surface Disease: An In Vivo Confocal Microscopy Study. | Q50544956 | ||
| Application of umbilical cord serum eyedrops for recurrent corneal erosions. | Q51487319 | ||
| Long-term follow up of autologous serum treatment for recurrent corneal erosions. | Q51566630 | ||
| Reflections on Dry Eye Syndrome Treatment: Therapeutic Role of Blood Products. | Q52661549 | ||
| Autologous serum for the treatment of corneal epithelial abrasions in diabetic patients undergoing vitrectomy | Q80021611 | ||
| Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome | Q80309183 | ||
| Allogeneic serum eye drops for the treatment of persistent corneal epithelial defect | Q80477962 | ||
| Allogeneic serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease | Q80714148 | ||
| An optimised protocol for the production of autologous serum eyedrops | Q81499524 | ||
| Application of umbilical cord serum eyedrops for the treatment of dry eye syndrome | Q83190247 | ||
| Corneal epitheliotrophic capacity of three different blood-derived preparations | Q83839637 | ||
| Plasma rich in growth factors as a therapeutic agent for persistent corneal epithelial defects | Q84318403 | ||
| Evaluation of umbilical cord serum therapy in acute ocular chemical burns | Q84386800 | ||
| Autologous serum 50% eyedrops in the treatment of persistent corneal epithelial defects | Q84513683 | ||
| Topical autologous platelet-rich plasma eyedrops for acute corneal chemical injury | Q84514836 | ||
| Comparison of autologous serum eye drops with different diluents | Q84886636 | ||
| Stability of serum eye drops after storage of 6 months | Q84942235 | ||
| Effect of autologous platelet-rich plasma on persistent corneal epithelial defect after infectious keratitis | Q84966310 | ||
| Improving the anti-inflammatory effect of serum eye drops using allogeneic serum permissive for regulatory T cell induction | Q85604357 | ||
| The application of autologous serum eye drops in severe dry eye patients; subjective and objective parameters before and after treatment | Q86051292 | ||
| Comparison of clinical efficacies of autologous serum eye drops in patients with primary and secondary Sjögren syndrome | Q88003451 | ||
| Serum drops for ocular surface disease: national survey of Canadian cornea specialists | Q88761631 | ||
| Visual acuity and quality of life in dry eye disease: Proceedings of the OCEAN group meeting | Q88897499 | ||
| Plasma Rich in Growth Factors for the Treatment of Dry Eye after LASIK Surgery | Q89052706 | ||
| Safety and Efficacy of Autologous Plasma Rich in Growth Factors Eye Drops for the Treatment of Evaporative Dry Eye | Q89295221 | ||
| Randomised, prospective clinical trial of platelet-rich plasma injection in the management of severe dry eye | Q89408581 | ||
| Application of autologous serum eye drops after pterygium surgery: a prospective study | Q90323769 | ||
| Clinical Efficacy of Platelet-Rich Plasma in the Treatment of Neurotrophic Corneal Ulcer | Q90353734 | ||
| Plasma rich in growth factors for the treatment of dry eye from patients with graft versus host diseases | Q90750010 | ||
| A retrospective crossover study of autologous and allogeneic serum eye drops for the management of ocular surface disease | Q90751672 | ||
| In Vivo Confocal Microscopy Automated Morphometric Analysis of Corneal Subbasal Nerve Plexus in Patients With Dry Eye Treated With Different Sources of Homologous Serum Eye Drops | Q92033508 | ||
| Efficacy and safety of treatment of hyposecretory dry eye with platelet-rich plasma | Q93204493 | ||
| Autologous Serum and Serum Components | Q93343235 | ||
| A Single-Center Pilot Prospective Study of Topical Application of Platelet-Derived Eye Drops for Patients with Ocular Chronic Graft-versus-Host Disease. | Q52865411 | ||
| Evaluation of the Role of Umbilical Cord Serum and Autologous Serum Therapy in Reepithelialization After Keratoplasty: A Randomized Controlled Clinical Trial. | Q53096488 | ||
| Comparison of Amniotic Membrane Transplantation and Umbilical Cord Serum in Acute Ocular Chemical Burns: A Randomized Controlled Trial. | Q53096785 | ||
| Corneal Epithelial Wound Healing. | Q53366417 | ||
| Application of umbilical cord serum eyedrops for the treatment of neurotrophic keratitis. | Q53492811 | ||
| The Effect of Immunologically Safe Plasma Rich in Growth Factor Eye Drops in Patients with Sjögren Syndrome. | Q53509223 | ||
| Therapeutic effect of umbilical cord serum eyedrops for the treatment of dry eye associated with graft-versus-host disease. | Q53581158 | ||
| Therapeutic effect of umbilical cord serum eyedrops for persistent corneal epithelial defect. | Q53612622 | ||
| Allogeneic serum eye drops: time these became the norm? | Q53887727 | ||
| Randomized double-blind clinical trial of autologous serum versus artificial tears in dry eye syndrome. | Q55056224 | ||
| Neurotrophic keratitis: current challenges and future prospects. | Q55664586 | ||
| Comparison of growth factor and interleukin content of adult peripheral blood and cord blood serum eye drops for cornea and ocular surface diseases | Q56379460 | ||
| WHO Expert Committee on biological standardization | Q57114185 | ||
| Time- and Temperature-Dependent Stability of Growth Factor Peptides in Human Autologous Serum Eye Drops | Q58134951 | ||
| Autologous platelet lysate for treatment of refractory ocular GVHD | Q61631252 | ||
| Platelet-rich plasma in the management of chronic low back pain: a critical review | Q64105703 | ||
| Clinical Experience With a Mobile Ocular Perfusion Pump | Q67320795 | ||
| Distribution of epidermal growth factor (EGF) receptors in rabbit corneal epithelial cells, keratocytes and endothelial cells, and the changes induced by transforming growth factor-beta 1 | Q68065311 | ||
| Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca | Q71320063 | ||
| Treatment of persistent corneal epithelial defect by autologous serum application | Q73078990 | ||
| The effects of growth factors and conditioned media on the proliferation of human corneal epithelial cells and keratocytes | Q74148599 | ||
| Use of autologous platelet-rich plasma in the treatment of dormant corneal ulcers | Q79835914 | ||
| Symptomatic dry eye treatment with autologous platelet-rich plasma | Q79997646 | ||
| The key role of insulin-like growth factor I in limbal stem cell differentiation and the corneal wound-healing process | Q36451149 | ||
| Autologous Platelet-rich Plasma Eye Drops in the Treatment of Recurrent Corneal Erosions | Q36764408 | ||
| Stem Cells in the Limbal Stroma | Q36829075 | ||
| The Effect of Autologous Platelet Lysate Eye Drops: An In Vivo Confocal Microscopy Study | Q36864045 | ||
| Growth factors in the tear film: role in tissue maintenance, wound healing, and ocular pathology | Q36895303 | ||
| SIMTI recommendations on blood components for non-transfusional use. | Q37306796 | ||
| Undiluted Serum Eye Drops for the Treatment of Persistent Corneal Epitheilal Defects | Q37464184 | ||
| Cord blood serum-based eye drops: the impact of donor haematological and obstetric factors on the variability of epidermal growth factor levels | Q37602400 | ||
| Growth factor content in PRP and their applicability in medicine | Q38104497 | ||
| Implementation of a standardised method for the production of allogeneic serum eye drops from regular blood donors in a Norwegian University Hospital: Some methodological aspects and clinical considerations | Q38509346 | ||
| Serum eye drop preparation in Australia: Current manufacturing practice | Q38540177 | ||
| Autologous and allogeneic serum eye drops. The Dutch perspective | Q38542256 | ||
| Blood-derived topical therapy for ocular surface diseases | Q38547921 | ||
| Blood derived eye drops for the treatment of cornea and ocular surface diseases | Q38636912 | ||
| TFOS DEWS II Epidemiology Report | Q38652994 | ||
| TFOS DEWS II Definition and Classification Report. | Q38665717 | ||
| Treatment of patients with neurotrophic keratitis stages 2 and 3 with plasma rich in growth factors (PRGF-Endoret) eye-drops. | Q38723051 | ||
| Comparison of epitheliotrophic factors in autologous serum eyedrops from sera of chronic renal failure patients vs. normal controls | Q38869251 | ||
| Serum eye drops: a survey of international production methods. | Q38884551 | ||
| Ready-made allogeneic ABO-specific serum eye drops: production from regular male blood donors, clinical routine, safety and efficacy | Q39210170 | ||
| The efficacy of autologous serum eye drops for severe dry eye syndrome: a randomized double-blind crossover study | Q39211271 | ||
| Efficacy of standardized and quality-controlled cord blood serum eye drop therapy in the healing of severe corneal epithelial damage in dry eye. | Q39242352 | ||
| In vitro effects of three blood derivatives on human corneal epithelial cells. | Q39316182 | ||
| TFOS DEWS II Management and Therapy Report | Q39453364 | ||
| Treatment of severe chronic ocular graft-versus-host disease using 100% autologous serum eye drops from a sealed manufacturing system: a retrospective cohort study | Q39706535 | ||
| Autologous fibrin membrane combined with solid platelet-rich plasma in the management of perforated corneal ulcers: a pilot study | Q40103025 | ||
| Long-term safety and efficacy of autologous platelet lysate drops for treatment of ocular GvHD. | Q40594903 | ||
| Topical 100% serum eye drops for treating corneal epithelial defect after ocular surgery | Q42041153 | ||
| Effect of Autologous Serum Eye Drops in Patients with Sjögren Syndrome-related Dry Eye: Clinical and In Vivo Confocal Microscopy Evaluation of the Ocular Surface | Q42501419 | ||
| Comparison of application systems for autologous serum eye drops | Q42636537 | ||
| Allogeneic blood-based therapies: hype or hope? | Q42696117 | ||
| The effect of topical autologous serum on graft re-epithelialization after penetrating keratoplasty. | Q43005037 | ||
| Controlled study of the use of autologous serum in dry eye patients. | Q43783612 | ||
| Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease | Q44401535 | ||
| Comparative role of 20% cord blood serum and 20% autologous serum in dry eye associated with Hansen's disease: a tear proteomic study | Q44412563 | ||
| Autologous serum eye drops diluted with sodium hyaluronate: clinical and experimental comparative study | Q44717461 | ||
| Autologous serum application in the treatment of neurotrophic keratopathy | Q44921560 | ||
| The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study | Q45284543 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 9 | |
| P921 | main subject | eye disease | Q3041498 |
| P577 | publication date | 2019-09-17 | |
| P1433 | published in | Journal of Clinical Medicine | Q27724774 |
| P1476 | title | Blood-Based Treatments for Severe Dry Eye Disease: The Need of a Consensus | |
| P478 | volume | 8 |
Search more.